UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Top-30 makers produce more than half of drugs
Drug output by 30 largest pharmaceutical companies accounted for 54 percent...
by Lee Hye-seon
|
2019-07-29 16:38
라인
Researchers develop next-generation immunotherapy
Researchers at CHA Bundang Medical Center have developed a new treatment th...
by Lee Han-soo
|
2019-07-29 16:37
라인
CNUHH introduces Korea’s 1st 4K-3D laparoscopic surgical system
Chonnam National University Hwasun Hospital (CNUHH) has become the first Ko...
by Lee Han-soo
|
2019-07-29 14:23
라인
‘Premature short babies more vulnerable to chronic lung disease’
Researchers at Seoul National University Bundang Hospital have discovered t...
by Lee Han-soo
|
2019-07-29 12:04
라인
Takeda’s Zejula poised to change local ovarian cancer treatment market
Takeda’s Zejula (ingredient: niraparib) became eligible for an insurance be...
by Kim Yun-mi
|
2019-07-29 12:04
라인
Pfizer's Besponsa, Takeda's Zejula likely to get insurance coverage
Pfizer's Besponsa, a B-cell lymphoblastic leukemia treatment, and Taked...
by Lee Han-soo
|
2019-07-26 17:57
라인
Court extends ‘temporary suspension’ of order to cancel Invossa trials
A local court has decided to temporarily suspend the legal effect of an adm...
by Jeong Sae-im
|
2019-07-26 17:50
라인
SNUBH professor is 1st Asian keynoter at international Alzheimer meet
Professor Kim Sang-yun of Seoul National University Bundang Hospital has be...
by Lee Han-soo
|
2019-07-26 16:08
라인
‘Kolon Life Science to start following up on Invossa-treated patients’
Kolon Life Science will conduct the first test on patients who received Inv...
by Lee Han-soo
|
2019-07-26 12:21
라인
Biotech industry group urges Japan to withdraw export curbs
Korea Biotechnology Industry Organization has delivered a written request t...
by Jeong Sae-im
|
2019-07-25 17:09
라인
JVM posts ₩25.8 billion in H1 sales
JVM, a subsidiary of Hanmi Pharmaceutical, said Thursday that it recorded 2...
by Lee Han-soo
|
2019-07-25 17:05
라인
JW Creagene wins US patent for making dendritic cell treatment
JW Creagene said Thursday that it has obtained a patent for its source tech...
by Lee Han-soo
|
2019-07-25 16:39
라인
Merck, Pfizer launch metastatic merkel cell carcinoma treatment in Korea
Merck and Pfizer will address the unmet medical need of patients suffering ...
by Lee Han-soo
|
2019-07-25 15:18
라인
[Focus] Korean biopharmas eye US Humira market
Samsung Bioepis’s Humira biosimilar has secured entry into the U.S. market....
by Jeong Sae-im
|
2019-07-25 15:02
라인
IBS identifies brain drainage pathway that induces dementia
Researchers at the Institute for Basic Science (IBS) have succeeded in reve...
by Lee Han-soo
|
2019-07-25 11:18
라인
Kolon Life Science ends Invossa deal with Hong Kong partner
Kolon Life Science said it has terminated the supply agreement of Invossa-K...
by Lee Han-soo
|
2019-07-25 11:17
라인
Samsung BioLogics records Q2 operating loss
Samsung BioLogics logged an operating loss of 5.4 billion won ($13.1 millio...
by Lee Han-soo
|
2019-07-25 10:16
라인
Doctor-patient telemedicine allowed as 1st step of Moon’s regulation-free zones
Telemedicine between doctors and patients will be allowed in Gangwon Provin...
by Kwak Sung-sun
|
2019-07-24 18:02
라인
KUGH develop new micro liquid analysis technology using wave energy
Researchers at Korea University Guro Hospital (KUGH) have developed a techn...
by Lee Han-soo
|
2019-07-24 18:00
라인
Samsung Bioepis biosimilar sales in EU top $180 million in Q1
Samsung Bioepis’ sales in the European Union surpassed $180 million in the ...
by Lee Han-soo
|
2019-07-24 15:29
-
이전
101
102
103
104
105
106
107
108
109
110
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top